Two-Drug GVHD Prophylaxis With Cyclophosphamide Prevails for Stem Cell Transplant

(MedPage Today) — Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclosporin prophylaxis, a randomized trial showed.
Median…